391 results on '"Cooper, Nichola"'
Search Results
2. Long-term treatment with rilzabrutinib in patients with immune thrombocytopenia
3. Evaluating the clinical validity of genes related to hemostasis and thrombosis using the Clinical Genome Resource gene curation framework
4. The role of CD8+ T-cell clones in immune thrombocytopenia
5. A single-arm, long-term efficacy and safety study of subcutaneous romiplostim in children with immune thrombocytopenia
6. Whole genome sequences discriminate hereditary hemorrhagic telangiectasia phenotypes by non-HHT deleterious DNA variation
7. Third primary SARS-CoV-2 mRNA vaccines enhance antibody responses in most patients with haematological malignancies
8. Transcriptional reprogramming from innate immune functions to a pro-thrombotic signature by monocytes in COVID-19
9. Tocilizumab in patients hospitalised with COVID-19 pneumonia: Efficacy, safety, viral clearance, and antibody response from a randomised controlled trial (COVACTA)
10. Iron status influences the response of cord blood megakaryocyte progenitors to eltrombopag in vitro
11. Autocrine vitamin D signaling switches off pro-inflammatory programs of TH1 cells
12. Psychometric Evaluation of ITP Life Quality Index (ILQI) in a Global Survey of Patients with Immune Thrombocytopenia
13. Bone marrow remodeling supports hematopoiesis in response to immune thrombocytopenia progression in mice
14. Romiplostim in children with newly diagnosed or persistent primary immune thrombocytopenia
15. International survey on Helicobacter pylori testing in patients with immune thrombocytopenia: Communication of the platelet immunology scientific and standardization committee
16. Identification of occult cerebral microbleeds in adults with immune thrombocytopenia
17. Real‐world use of thrombopoietin receptor agonists for the management of immune thrombocytopenia in adult patients in the United Kingdom: Results from the TRAIT study.
18. Multi-arm Trial of Inflammatory Signal Inhibitors (MATIS) for hospitalised patients with mild or moderate COVID-19 pneumonia: a structured summary of a study protocol for a randomised controlled trial
19. American Society of Hematology 2019 guidelines for immune thrombocytopenia
20. Diagnostic high-throughput sequencing of 2396 patients with bleeding, thrombotic, and platelet disorders
21. Updated international consensus report on the investigation and management of primary immune thrombocytopenia
22. The role of Protein Kinase Cα in the skin and cutaneous wound healing
23. Management of immune thrombocytopenia in elderly patients
24. Human retinoic acid–regulated CD161+ regulatory T cells support wound repair in intestinal mucosa
25. Investigating the therapeutic options and pathobiology of immune thrombocytopenic purpura in adults
26. Eltrombopag: a powerful chelator of cellular or extracellular iron(III) alone or combined with a second chelator
27. Presenting ADAMTS13 antibody and antigen levels predict prognosis in immune-mediated thrombotic thrombocytopenic purpura
28. Thrombocytopenia
29. Safety and efficacy of SARS‐CoV‐2 vaccination in patients with immune thrombocytopenia: A two‐centre review.
30. Sustained response off‐treatment in eltrombopag‐treated adult patients with ITP who are refractory or relapsed after first‐line steroids: Primary, final, and ad‐hoc analyses of the Phase II TAPER trial.
31. Recent advances in understanding spleen tyrosine kinase (SYK) in human biology and disease, with a focus on fostamatinib.
32. European Delphi panel to build consensus on tapering and discontinuing thrombopoietin receptor agonists in immune thrombocytopenia.
33. Could machine learning revolutionize how we treat immune thrombocytopenia?
34. Differential effects of mycophenolate mofetil and cyclosporine A on peripheral blood and cord blood natural killer cells activated with interleukin-2
35. Regulatory B cells are enriched within the IgM memory and transitional subsets in healthy donors but are deficient in chronic GVHD
36. A HaemSTAR-led, UK-wide 'flash-mob’ audit of intravenous immunoglobulin use in immune thrombocytopenia
37. A United Kingdom Immune Thrombocytopenia (ITP) Forum review of practice: thrombopoietin receptor agonists
38. GWAS meta-analysis of intrahepatic cholestasis of pregnancy implicates multiple hepatic genes and regulatory elements
39. Efficacy and safety of the thrombopoietin receptor agonist romiplostim in patients aged ≥65 years with immune thrombocytopenia
40. Total Body Irradiation Is Associated with Higher Prevalence of Cerebral Microbleeds in Haematopoietic Stem Cell Transplant Survivors
41. Clinical Predictors of Response to Rilzabrutinib Therapy in Patients with Immune Thrombocytopenia: Exploratory Analysis of a Phase 1/2 Study
42. Safety and Efficacy of SARS-CoV-2 Vaccination in Patients with Immune Thrombocytopaenia: a Multi-Centre Review
43. Retrospective, Observational, Multicenter Study Assessing the Thrombopoietin Receptor Agonist (TPO-RA) Romiplostim and Other Treatments for Patients with Newly Diagnosed or Persistent Primary Immune Thrombocytopenia (ITP) in Routine Clinical Practice in the United Kingdom (UK)
44. Tyrosine kinase inhibitors impair B-cell immune responses in CML through off-target inhibition of kinases important for cell signaling
45. Standardization of bleeding assessment in immune thrombocytopenia: report from the International Working Group
46. Phenotypic Characterization of EIF2AK4 Mutation Carriers in a Large Cohort of Patients Diagnosed Clinically With Pulmonary Arterial Hypertension
47. Immune thrombocytopenia: a need for assisted suicide
48. The effect of TRV027 on coagulation in COVID-19: A pilot randomized, placebo-controlled trial.
49. Rozrolimupab, a mixture of 25 recombinant human monoclonal RhD antibodies, in the treatment of primary immune thrombocytopenia
50. Outcomes 5 years after response to rituximab therapy in children and adults with immune thrombocytopenia
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.